175 related articles for article (PubMed ID: 1375675)
1. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats.
Nakajima T; Yamada T; Setoguchi M
J Cardiovasc Pharmacol; 1992 Jan; 19(1):102-7. PubMed ID: 1375675
[TBL] [Abstract][Full Text] [Related]
2. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Yaoka O; Aoki K; Nakajima T; Setoguchi M
Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
[TBL] [Abstract][Full Text] [Related]
3. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
Edling O; Bao G; Feelisch M; Unger T; Gohlke P
J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
[TBL] [Abstract][Full Text] [Related]
4. Effect of enalapril and quinapril on forearm vascular ACE in man.
Lyons D; Webster J; Benjamin N
Eur J Clin Pharmacol; 1997; 51(5):373-8. PubMed ID: 9049577
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters.
Benetos A; Albaladejo P; Levy BI; Safar ME
J Hypertens Suppl; 1994 Jul; 12(4):S21-9. PubMed ID: 7965270
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
Lear W; Ruzicka M; Leenen FH
Am J Physiol; 1997 Aug; 273(2 Pt 2):H641-6. PubMed ID: 9277479
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.
Fabris B; Chen BZ; Pupic V; Perich R; Johnston CI
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S6-13. PubMed ID: 1691409
[TBL] [Abstract][Full Text] [Related]
8. Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats.
Schaison FH; Fernando Ramirez-Gil J; Ciferri S; Bernard M; Baudin B; Mougenot N; Carayon A; Lechat P
J Cardiovasc Pharmacol; 1996 Jul; 28(1):11-8. PubMed ID: 8797130
[TBL] [Abstract][Full Text] [Related]
9. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
Ruzicka M; Skarda V; Leenen FH
Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
[TBL] [Abstract][Full Text] [Related]
10. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
11. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.
Arvola P; Ruskoaho H; Wuorela H; Pekki A; Vapaatalo H; Pörsti I
Br J Pharmacol; 1993 Apr; 108(4):980-90. PubMed ID: 8485636
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril.
Largo R; Gómez-Garre D; Liu XH; Alonso J; Blanco J; Plaza JJ; Egido J
Hypertension; 1997 May; 29(5):1178-85. PubMed ID: 9149684
[TBL] [Abstract][Full Text] [Related]
13. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
15. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and morphological effects of quinapril during genetic hypertension development.
Richer C; Mulder P; Fornes P; Richard V; Camilleri JP; Giudicelli JF
J Cardiovasc Pharmacol; 1991 Oct; 18(4):631-42. PubMed ID: 1724542
[TBL] [Abstract][Full Text] [Related]
17. Quinapril: overview of preclinical data.
Kaplan HR; Taylor DG; Olson SC
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII6-12. PubMed ID: 2189623
[TBL] [Abstract][Full Text] [Related]
18. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
Major TC; Overhiser RW; Taylor DG; Panek RL
J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
[TBL] [Abstract][Full Text] [Related]
19. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
Ono H; Ono Y; Frohlich ED
Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
[TBL] [Abstract][Full Text] [Related]
20. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
